Canadian Agency for Drugs and Technologies in Health Appoints Core Members to its New Health Technology Expert Review Panel
September 15, 2011
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of Core Members to its newly established Health Technology Expert Review Panel. This Panel is an advisory body, convened to develop guidance and recommendations on non-drug health technologies to CADTH. The Panel will consist of Core Members, appointed to serve for all topics under consideration, and Expert Members, who will be appointed on a per-project basis, providing expertise on specific topics.
Dr. Brian O’Rourke, President and Chief Executive Officer of CADTH, is pleased to welcome Dr. Devidas (Dev) Menon as Chair of the Panel. Currently, Professor of Health Policy and Management at the University of Alberta. Dr. Menon was the founding Executive Director of the Canadian Coordinating Office for Health Technology Assessment (CCOHTA; now CADTH), and Alberta’s Board representative to CCOHTA for one year. He has an extensive publication record in health technology assessment and evidence-informed policy-making.
The other Core Members are Dr. Charlotte Moore, Assistant Professor, Paediatrics, University of Toronto, Ontario; Dr. Lisa Schwartz, Associate Professor, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario; and Dr. Stirling Bryan, Director, Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute in British Columbia, and Stanford Health Policy Adjunct Associate.
“The newly appointed Core Members will bring a wealth of health care experience to this Panel,” said Dr. O’Rourke. “They will foster a consistent approach to the assessment of health technologies such as medical devices, diagnostic tests, and medical and surgical procedures.”
The selection process for a public member to serve on this Panel is currently underway.
The Canadian Agency for Drugs and Technologies in Health is an independent, not-for-profit organization funded by the federal, provincial, and territorial governments of Canada. CADTH is one of Canada’s leading sources of information and advice on the effectiveness and efficiency of drugs, medical devices, and other health technologies.
For more information:
John Yan, Director, Communications and Government Relations
Canadian Agency for Drugs and Technologies in Health
Janis Bogart, Communications Officer